Race Adjustment of Pulmonary Function Tests in the Diagnosis and Management of COPD: A Scoping Review
- PMID: 38708410
- PMCID: PMC11067926
- DOI: 10.2147/COPD.S430249
Race Adjustment of Pulmonary Function Tests in the Diagnosis and Management of COPD: A Scoping Review
Abstract
Aim: Increasing evidence suggests that the inclusion of self-identified race in clinical decision algorithms may perpetuate longstanding inequities. Until recently, most pulmonary function tests utilized separate reference equations that are race/ethnicity based.
Purpose: We assess the magnitude and scope of the available literature on the negative impact of race-based pulmonary function prediction equations on relevant outcomes in African Americans with COPD.
Methods: We performed a scoping review utilizing an English language search on PubMed/Medline, Embase, Scopus, and Web of Science in September 2022 and updated it in December 2023. We searched for publications regarding the effect of race-specific vs race-neutral, race-free, or race-reversed lung function testing algorithms on the diagnosis of COPD and COPD-related physiologic and functional measures. Joanna Briggs Institute (JBI) guidelines were utilized for this scoping review. Eligibility criteria: The search was restricted to adults with COPD. We excluded publications on other lung disorders, non-English language publications, or studies that did not include African Americans. The search identified publications. Ultimately, six peer-reviewed publications and four conference abstracts were selected for this review.
Results: Removal of race from lung function prediction equations often had opposite effects in African Americans and Whites, specifically regarding the severity of lung function impairment. Symptoms and objective findings were better aligned when race-specific reference values were not used. Race-neutral prediction algorithms uniformly resulted in reclassifying severity in the African Americans studied.
Conclusion: The limited literature does not support the use of race-based lung function prediction equations. However, this assertion does not provide guidance for every specific clinical situation. For African Americans with COPD, the use of race-based prediction equations appears to fall short in enhancing diagnostic accuracy, classifying severity of impairment, or predicting subsequent clinical events. We do not have information comparing race-neutral vs race-based algorithms on prediction of progression of COPD. We conclude that the elimination of race-based reference values potentially reduces underestimation of disease severity in African Americans with COPD.
Keywords: African Americans; lung function prediction equations; lung function tests.
© 2024 Davidson et al.
Conflict of interest statement
The authors declare no conflicts of interest in this work
Similar articles
-
What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical indication and in subgroups of patients with common comorbidities: a systematic review of the clinical and cost-effective literature.Health Technol Assess. 2012 Dec;16(50):i-xvi, 1-159. doi: 10.3310/hta16500. Health Technol Assess. 2012. PMID: 23302507 Free PMC article.
-
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2. Cochrane Database Syst Rev. 2017. PMID: 28535331 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2. Cochrane Database Syst Rev. 2022. PMID: 36373977 Free PMC article.
-
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD013139. doi: 10.1002/14651858.CD013139.pub2. Cochrane Database Syst Rev. 2021. PMID: 34931303 Free PMC article.
Cited by
-
Effectiveness of adding a peak flow meter for the identification of patients with chronic obstructive pulmonary disease in real-world clinical practice.BMC Pulm Med. 2025 May 17;25(1):239. doi: 10.1186/s12890-025-03708-8. BMC Pulm Med. 2025. PMID: 40382611 Free PMC article.
-
Race-Based Pulmonary Function Testing Correction in COPD Inhaler Therapy Trials: A Systematic Review.Int J Chron Obstruct Pulmon Dis. 2024 Oct 12;19:2285-2297. doi: 10.2147/COPD.S475875. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 39416876 Free PMC article.
-
The chronological age at which small airway function starts to decline in a healthy Chinese population: a cross-sectional study.Front Allergy. 2025 Jul 10;6:1614899. doi: 10.3389/falgy.2025.1614899. eCollection 2025. Front Allergy. 2025. PMID: 40709067 Free PMC article.
References
-
- World Health Organization. Chronic obstructive pulmonary disease (COPD); 2023. Available From https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pul...). Accessed March 1, 2024.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical